Sutrobio
Sutrobio, based in South San Francisco, CA, is dedicated to revolutionizing vaccine development with a mission to eliminate bacterial infections such as invasive pneumococcal disease, Group A Streptococcus, and Shigella. The company leverages advanced chemistry and synthetic techniques to produce high-fidelity, broad-spectrum vaccines that aim to protect vulnerable populations worldwide.
With a focus on innovative pneumococcal conjugate vaccines like VAX-31 and VAX-24, Sutrobio is setting a new standard for immunogenicity in vaccine technology. Their site-specific carrier-sparing platform is designed to enhance vaccine effectiveness against both currently circulating and historically prevalent serotypes, while additional candidates are in early development to address other bacterial threats.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.
Partial Data by Foursquare.